Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05239572
Other study ID # 202100908
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 31, 2022
Est. completion date June 30, 2023

Study information

Verified date October 2023
Source University Medical Center Groningen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The SUNI-SEA study is an intervention study that measures effectiveness and cost-effectiveness of prevention and early diagnosis of diabetes and cardiovascular diseases in communities and primary healthcare (PHC) facilities in Indonesia, Myanmar and Vietnam.


Description:

The study takes place in Vietnam and Indonesia in Intergenerational Self-Help Clubs (ISHGs), where community members assemble for activities concerning social, economical improvement and health and well-being. Volunteers in these ISHGs are trained in performing screening for diabetes and cardiovascular diseases and counselling participants concerning healthy living, or referral to primary healthcare facilities, if needed. At PHC level further diagnosis and if needed treatment is provided and referral back to ISHGs is done for lifestyle interventions. In Indonesia screening takes place in the Posbindu programme, where trained volunteers (cadres) screen and counsel participants. If needed referral to Puskesmas (primary healthcare facilities is done, where further diagnosis and treatment takes place. Activities for health promotion and lifestyle interventions take place under supervision of the Posbindu programme. In Myanmar and Indonesia individual monitoring and health education of participants is done through mobile applications. Measuring of uptake, follow-up and adherence to interventions is done through routine data collection, through surveys, and through semi-structured interviews and focus group discussions.


Recruitment information / eligibility

Status Completed
Enrollment 16850
Est. completion date June 30, 2023
Est. primary completion date June 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: - All adults living in geographical area where research takes place Exclusion Criteria: - Persons who are not able to come to location of screening, due to illness or other chronic condition causing immobility.

Study Design


Intervention

Combination Product:
screening, prevention and counselling
Screening in Intergenerational solidarity clubs in Myanmar and Vietnam and in Posbindu programme in Indonesia

Locations

Country Name City State
Vietnam Health Strategy and Policy Institute Hanoi

Sponsors (8)

Lead Sponsor Collaborator
University Medical Center Groningen Health Strategy and Policy Institute, HelpAge International, Thai Nguy?n University of Medicine and Pharmacy, Trnavska Universita v Trnava, Universitas Sebelas Maret, University of Groningen, University of Passau

Country where clinical trial is conducted

Vietnam, 

Outcome

Type Measure Description Time frame Safety issue
Other Impact of training of community health volunteers in NCD interventions on knowledge attitudes and practices of volunteers Difference in knowledge, attitudes and practices (KAP) of volunteers in ISHCs in Myanmar and Vietnam, and cadres in Posbindu in Indonesia as result of training offered in the research project, measured by pre- and post-training KAP survey and six months after training. 6 months between provision of training to community health volunteers and measuring their skills, knowledge and attitudes
Other Impact of training of community health volunteers on their performance in NCD interventions. Performance of community health volunteers six months after training, measured by observational study, with measuring adherence to standard operating procedures for screening for NCDs and health education. 6 months between provision of training to community health volunteers and measuring their performance
Primary Uptake of NCD screening offered in communities Number of adults eligible for NCD screening in communities who participate in screening 18 months from offering screening options in communities until measuring uptake
Primary Adherence to follow-up advice Percentage of participants in screening who follow up on recommendations given during screening (referral, lifestyle change) 12 months from counselling and advice to individual until measuring adherence to follow-up that has been recommended
Primary Uptake of health education (health promotion, awareness of risk factors) Percentage of adults above 21 years in communities participating in one or more health education sessions offered 12 year between first health education session and measuring uptake (based on participants' lists)
Secondary Unit costs of screening, prevention and early diagnosis of NCDs per Quality Adjusted Life Year gained Unit costs of NCD screening, prevention, early diagnosis intervention per Quality Adjusted Life Year gained 18 months between starting calculation of costs of interventions and assessment of final assessment of benefits
Secondary Cost-effectiveness of NCD interventions Comparison of costs and effects between intervention and business as usual, using diff in diff method 18 months between baseline survey and endline survey
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A